The correlation between syntenin expression and tumor size (P = 0.011), lymph node status (P = 0.001), and recurrence (P = 0.002) was statistically significant, supporting the conclusion that syntenin is involved in breast cancer progression and metastasis. This evidence concerns the gene SDCBP and breast carcinoma.